In multiple studies, the key inflammatory marker C-reactive Protein (CRP) has been widely associated with cancer survival; predicting cancer risk; a bio-maker for tumour recurrence; as a marker in oncology for prognosis; and as a reliable tool for making critical treatment decisions for several cancer types. Here, CRP is linked to cancer.